Neurological manifestations of HIV-1 infection in the HAART era. (Q34378701)

1 August 2017

1 reference

title

Neurological manifestations of HIV-1 infection in the HAART era. (English)

1 reference

1 August 2017

Geraci AP

1 reference

1 August 2017

Simpson DM

series ordinal

1 reference

1 August 2017

language of work or name

1 reference

1 January 2001

1 reference

1 August 2017

published in

Comprehensive Therapy

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

232-241

1 reference

AIDS commentary. Toxoplasmic encephalitis

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

Hiccups, toxoplasmosis, and AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

Management of intracerebral lesions in patients with HIV: a retrospective study with discussion of diagnostic problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

Primary central nervous system lymphoma versus toxoplasmosis in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

Primary Central Nervous System Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

Subacute encephalomyelitis of AIDS and its relation to HTLV-III infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

A phase I/II trial of nimodipine for HIV-related neurologic complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

Transdermal selegiline in HIV-associated cognitive impairment: pilot, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

Dissociation of AIDS-related vacuolar myelopathy and productive HIV-1 infection of the spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

The neuromuscular manifestations of human immunodeficiency virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

Prognosis in AZT myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

Regression of HIV encephalopathy and basal ganglia signal intensity abnormality at MR imaging in patients with AIDS after the initiation of protease inhibitor therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

Antiretroviral therapy may improve sensory function in HIV-infected patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12019-001-0020-6

10.1007/S12019-001-0020-6

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference